Huizhou Central People's Hospital
In research, Huizhou Central People's Hospital stands highest in Medicine (#3,883 of 10,443 worldwide), Health Sciences (#5,140 of 11,982 worldwide) and Life Sciences (#3,858 of 7,800 worldwide), 2022–2025.
- World rank, 2022–2025
- #7,923 of 28,054 · #16,902 all time
- Rank in China
- #1,563 of 3,058
- Research works
- 2.2k ▼ 38% vs 2013–17
- Citations
- 7.2k 3.4 per fractional work
- Top-10% rate
- 17.5% record average 16.5%
- Open access
- 22% world 28%
What is Huizhou Central People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,883 of 10,443 | 18.0% | 198 | #6904 | |
| Health SciencesDomain | #5,140 of 11,982 | 18.0% | 204 | #8698 | |
| Life SciencesDomain | #3,858 of 7,800 | 15.0% | 91 | #7942 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,305 of 3,579 | 12.3% | 66 | #6911 |
Each strip is that field’s whole ranked pool, with the notch where Huizhou Central People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#6,904 #3,883
- Health Sciences#8,698 #5,140
- Life Sciences#7,942 #3,858
- Biochemistry, Genetics and Molecular Biology#6,911 #3,305
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.9×
- Immunology and Microbiology 3.6×
- Medicine 3.3×
- Neuroscience 2.0×
- Veterinary 1.7×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Dentistry 1.1×
- Nursing 0.8×
- Health Professions 0.2×
- Psychology 0.2×
- Chemistry 0.2×
- Materials Science 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Economics, Econometrics and Finance 0.1×
- Energy 0.1×
- Mathematics 0.1×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.0×
- Arts and Humanities 0.0×
- Earth and Planetary Sciences 0.0×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
Who are the top researchers at Huizhou Central People's Hospital?
Ranked on the composite score, Chun Xiao, Yukun Yang and Honglian Zhang lead among researchers whose main affiliation is Huizhou Central People's Hospital.
- 1 Chun Xiao China · #1,386,744 worldwide 15 citations · 27 works
- 2 Yukun Yang China · #1,446,489 worldwide 10 citations · 16 works
- 3 Honglian Zhang China · #1,472,978 worldwide 7 citations · 19 works
Which keywords describe research at Huizhou Central People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Gene Expression, Tumor Microenvironment, Regulation, Biogenesis and Epidemiology.
- Cancer Progression
- Long Noncoding RNAs
- Targeting
- GPX4
- Lipid Peroxidation
- Therapeutics
- Neuroinflammation
- Neuroprotection
- Circular RNAs
- Cellular Functions
- Metabolic Syndrome
- Immunotherapy
- Clinical Practice Guidelines
- Risk Factors
- Chemotherapy
- Cardiovascular Disease
- Biogenesis
- Regulation
- Oxidative Stress
- Inflammation
- Cancer
- Epidemiology
- Gene Expression
- Tumor Microenvironment
- Metastasis
- Biomarkers
- Cancer Biomarkers
- Treatment
- Cell Death
- Disease
- Global Burden
- Translation
- MicroRNA Sponges
- Epigenetic Regulation
- Apoptosis
- Immunity
- Ferroptosis
- MicroRNA
- Innate Immunity
- RNA Regulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer36▲ 8.7×40 topics
- Inflammation33▲ 5.0×70 topics
- Epidemiology28▲ 2.2×82 topics
- Oxidative Stress24▲ 4.6×43 topics
- Gene Expression17▲ 8.7×9 topics
- Regulation16▲ 9.2×8 topics
- Tumor Microenvironment16▲ 11×8 topics
- Biogenesis16▲ 28×3 topics
- Metastasis14▲ 13×11 topics
- Cardiovascular Disease13▲ 3.7×33 topics
- Biomarkers13▲ 6.0×15 topics
- Chemotherapy11▲ 5.1×21 topics
- Cancer Biomarkers11▲ 42×3 topics
- Risk Factors11▲ 3.2×23 topics
- Treatment11▲ 2.9×27 topics
- Clinical Practice Guidelines11▲ 6.3×14 topics
- Cell Death10▲ 14×6 topics
- Immunotherapy10▲ 4.5×16 topics
- Disease10▲ 35×2 topics
- Metabolic Syndrome9▲ 3.5×20 topics
- Global Burden9▲ 5.3×10 topics
- Cellular Functions9▲ 36×2 topics
- Translation8▲ 16×2 topics
- Circular RNAs8▲ 65×1 topic
- MicroRNA Sponges8▲ 65×1 topic
- Neuroprotection8▲ 7.5×13 topics
- Epigenetic Regulation8▲ 12×3 topics
- Neuroinflammation8▲ 8.4×6 topics
- Apoptosis7▲ 7.5×16 topics
- Therapeutics7▲ 20×2 topics
- Immunity7▲ 5.3×8 topics
- Lipid Peroxidation7▲ 21×3 topics
- Ferroptosis6▲ 27×1 topic
- GPX46▲ 27×1 topic
- MicroRNA6▲ 17×1 topic
- Targeting6▲ 27×1 topic
- Innate Immunity6▲ 6.1×10 topics
- Long Noncoding RNAs6▲ 23×1 topic
- RNA Regulation6▲ 19×1 topic
- Cancer Progression5▲ 8.9×6 topics
Which research topics does Huizhou Central People's Hospital publish most on?
By volume in 2022–2025: Circular RNAs in diseases, Ferroptosis and cancer prognosis, MicroRNA in disease regulation and Cancer-related molecular mechanisms research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Circular RNAs in diseases Molecular Biology 8 works
- 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
- 3 MicroRNA in disease regulation Cancer Research 6 works
- 4 Cancer-related molecular mechanisms research Cancer Research 6 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 6 Acute Ischemic Stroke Management Epidemiology 3 works
- 7 RNA modifications and cancer Molecular Biology 3 works
- 8 Glioma Diagnosis and Treatment Genetics 2 works
- 9 Inflammasome and immune disorders Molecular Biology 2 works
- 10 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Huizhou Central People's Hospital's research output changed?
Output in 2018–2022 was 38% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Huizhou
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.